Friday, September 20, 2013
GlaxoSmithKline Receives Anthrax Treatment Contract
British drugmaker GlaxoSmithKline announced Thursday that it has landed a four-year contract to supply an anthrax treatment to the U.S. government for use as a counter measure to a potential bioterrorist attack.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment